ONCHOCERCIASIS
Clinical trials for ONCHOCERCIASIS explained in plain language.
Never miss a new study
Get alerted when new ONCHOCERCIASIS trials appear
Sign up with your email to follow new studies for ONCHOCERCIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Massive trial tests new river blindness drug against standard treatment
Disease control CompletedThis large study compared the safety of a newer drug called moxidectin against the standard drug ivermectin for treating river blindness. It involved nearly 13,000 people aged 4 and older living in areas where the disease is common. Some participants also received an additional d…
Matched conditions: ONCHOCERCIASIS
Phase: PHASE3 • Sponsor: Medicines Development for Global Health • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Scientists test new Child-Friendly dose for devastating parasitic disease
Disease control CompletedThis study aimed to find the right dose of the medication moxidectin for children aged 4 to 11 years to treat river blindness (onchocerciasis). Researchers tested a single oral dose in 36 children and teenagers in Ghana to see how their bodies processed the drug and to check for …
Matched conditions: ONCHOCERCIASIS
Phase: PHASE1 • Sponsor: Medicines Development for Global Health • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC